Back to Search Start Over

Cell-based high-throughput screening of cationic polymers for efficient DNA and siRNA delivery.

Authors :
Wu Y
Wang L
Xiong Y
Zhou Q
Li L
Chen G
Ping Y
Davidson G
Levkin PA
Gao L
Deng W
Source :
Acta biomaterialia [Acta Biomater] 2020 Oct 01; Vol. 115, pp. 410-417. Date of Electronic Publication: 2020 Aug 25.
Publication Year :
2020

Abstract

Development of non-viral gene vectors which can efficiently and safely transfect plasmid DNA and siRNA into cells is of great importance for gene therapy. Despite lots of efforts spent, it is still imperative to develop suitable gene vectors with better transfection efficiency and low cytotoxicity. To this end, we successfully designed, synthesized and screened a library of 120 polymers (via nucleophilic substitution reaction between dihalides and amines). With cell-based transfection screening assays, 120 polymers were tested to evaluate their transfection efficiency of transporting DNA and siRNA into cells. Our results indicated that hydrophobic modification could greatly enhance cationic polymers' transfection efficiency, and polymers with long linkers usually showed better transfection performance, especially for polymers with the linker of 1, 12-dibromododecane (L3 linker). Besides, polyalkylamines exhibited better transfection efficiency with the polymer particle size around 200 nm and the zeta potential in the range of + 40 mV to +50 mV. Interestingly, polymer particles made from N15HL3 not only exhibited better DNA transfection efficiency in HEK 293T cells but also showed higher siRNA transfection efficiency in U87 Luc-GFP cells together with low cell toxicity than Lipofectamine 2000 (one of commercial transfection reagents). Therefore, it is hoped that our study here not only provides promising gene vector candidates for further evaluation in gene therapy, but also provides valuable insights for better understanding of the relationship between the chemical structures and gene transfection efficiency to rationally design better non-viral gene vectors for gene therapy in the future.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2020. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1878-7568
Volume :
115
Database :
MEDLINE
Journal :
Acta biomaterialia
Publication Type :
Academic Journal
Accession number :
32853811
Full Text :
https://doi.org/10.1016/j.actbio.2020.08.029